Projects per year
Organization profile
Organisation profile
The International Ph.D. Program for Translational Science in TMU (Taipei Medical University) provides comprehensive training programs for clinical and translational researches. In this program, we combine expertise from various fields including molecular biology, cancer biology, animal model, aging, proteomic and structural biology, and focus on the discovery and development of clinical biomarkers for oncology, neuroscience, reproductive medicine, stem cell and regenerative medicine. By translating the results of benchside research into bedside treatments, we look forward to enhancing the bio-pharmaceutical research, as well as improving the quality of clinical diagnosis and medical care.
Fingerprint
Dive into the research topics where International Ph.D. Program for Translational Science is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Profiles
-
Che-Chang Chang
- The Ph.D. Program for Translational Medicine - Associate Professor
- Graduate Institute of Biomedical Informatics - Associate Professor
- Master Program in Clinical Pharmacogenomics and Pharmacoproteomics - Joint-Appointment Associate Professor
- International Ph.D. Program for Translational Science - Joint-Appointment Associate Professor
Person: Researcher
-
Shu-Chun Chang
- The Ph.D. Program for Translational Medicine - Assistant Professor
- Graduate Institute of Biomedical Informatics - Assistant Professor
- International Ph.D. Program for Translational Science - Joint-Appointment Assistant Professor
Person: Researcher
-
Yi-Fan Chen
- The Ph.D. Program for Translational Medicine - Associate Professor
- Graduate Institute of Biomedical Informatics - Joint-Appointment Associate Professor
- International Ph.D. Program for Translational Science - Joint-Appointment Associate Professor
- TMU Research Center of Cancer Translational Medicine - Member
Person: Researcher
Projects
- 105 Finished
-
發展標靶CEACAM6的口腔癌治療診斷方法
1/1/20 → 12/31/20
Project: A - Government Institution › a - National Health Research Institutes
-
老化發炎現象所導致的外在調控可促進子宮內膜異位症的病程發展(I/II)
1/1/20 → 12/31/20
Project: A - Government Institution › d - Ministry of Education
-
以基因影像學技術應用於分析高風險兒童髓母細胞瘤使用奈米藥物標靶治療之療效
1/1/20 → 12/31/20
Project: A - Government Institution › d - Ministry of Education
Research output
-
Aged skeletal muscle retains the ability to remodel extracellular matrix for degradation of collagen deposition after muscle injury
Chen, W. J., Lin, I. H., Lee, C. W. & Chen, Y. F., Feb 2 2021, In: International journal of molecular sciences. 22, 4, p. 1-14 14 p., 2123.Research output: Contribution to journal › Article › peer-review
Open Access -
An integrated bioinformatics study of a novel niclosamide derivative, nsc765689, a potential gsk3β/β-catenin /stat3/ cd44 suppressor with anti-glioblastoma properties
Mokgautsi, N., Wen, Y. T., Lawal, B., Khedkar, H., Sumitra, M. R., Wu, A. T. H. & Huang, H. S., Mar 1 2021, In: International journal of molecular sciences. 22, 5, p. 1-23 23 p., 2464.Research output: Contribution to journal › Article › peer-review
Open Access -
Association of XRCC2 rs2040639 with the survival of patients with oral squamous cell carcinoma undergoing concurrent chemoradiotherapy
Senghore, T., Wang, W. C., Chien, H. T., Chen, Y. X., Young, C. K., Huang, S. F. & Yeh, C. C., Feb 2021, In: Gene. 768, p. 145283 145283.Research output: Contribution to journal › Article › peer-review
Datasets
-
Additional file 1: Figure S2. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y. (Contributor), Yang, C. (Contributor), Wei, P. (Contributor), Huynh, T. (Contributor), Whang-Peng, J. (Contributor), Meng, T. (Contributor), Hsiao, M. (Contributor), Tzeng, Y. (Contributor), Wu, T. A. (Contributor) & Yen, Y. (Contributor), Unknown Publisher, Feb 28 2017
DOI: 10.6084/m9.figshare.c.3704533_d2.v1, https://springernature.figshare.com/articles/presentation/Additional_file_1_Figure_S2_of_Ovatodiolide_suppresses_colon_tumorigenesis_and_prevents_polarization_of_M2_tumor-associated_macrophages_through_YAP_oncogenic_pathways/4701517/1
Dataset
-
Additional file 2: Figure S1. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y. (Contributor), Yang, C. (Contributor), Wei, P. (Contributor), Huynh, T. (Contributor), Whang-Peng, J. (Contributor), Meng, T. (Contributor), Hsiao, M. (Contributor), Tzeng, Y. (Contributor), Wu, T. A. (Contributor) & Yen, Y. (Contributor), Unknown Publisher, Feb 28 2017
DOI: 10.6084/m9.figshare.c.3704533_d1.v1, https://springernature.figshare.com/articles/presentation/Additional_file_2_Figure_S1_of_Ovatodiolide_suppresses_colon_tumorigenesis_and_prevents_polarization_of_M2_tumor-associated_macrophages_through_YAP_oncogenic_pathways/4701505/1
Dataset
-
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. (Contributor), Sung, P. (Contributor), Wu, T. A. (Contributor), Chou, P. (Contributor), Lin, J. (Contributor), Huang, C. F. (Contributor), Yeung, S. J. (Contributor) & Lee, M. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.12845528.v1, https://springernature.figshare.com/articles/figure/Additional_file_3_of_Neoadjuvant_metformin_added_to_conventional_chemotherapy_synergizes_anti-proliferative_effects_in_ovarian_cancer/12845528/1
Dataset